-退

Natalia Rosiak1, Ewa Tykarska2, Judyta Cielecka-Piontek1

  • 1Department of Pharmacognosy and Biomaterials, Faculty of Pharmacy, Poznan University of Medical Sciences, 3 Rokietnicka St., 60-806 Poznan, Poland.

PubMed
概括

这项研究开发了米瑞 (MYR) 与聚烯利 K30 (PVP30) 的无形固体分散 (ASD),以改善其溶解性和神经保护作用. MYR-PVP 1: 9 ASD 显示出增强的溶解性,抗氧化和神经保护性质,显示出治疗神经退行性疾病的前景.